Reuters news agency reported on Tuesday that Ukraine received its first batch of 500,000 doses of the AstraZeneca COVID-19 vaccine on 23 February 2021, allowing it to launch its delayed vaccine roll-out, starting with front-line medical workers and soldiers.
The President of Ukraine, Volodymyr Zelenskiy, tweeted: "We will start vaccination ASAP. We need to fight COVID together."
Ukraine's Health Minister, Maksym Stepanov, stated on Facebook: "Now we are urgently clearing the cargo through customs and the vaccine will immediately go to the regions."
Reportedly, Ukraine has lagged behind its neighbours in securing vaccines for its 41 million people, asking EU member states for help while refusing to buy the Sputnik V COVID-19 vaccine from Russia.
Ukraine had planned to launch mass vaccinations in mid-February 2021 through the global COVAX programme for poorer countries but the government said the roll-out was postponed due to a delay in delivery.
The current AstraZeneca doses were produced by the Serum Institute of India, and Ukraine approved the vaccine this week.
The health ministry said it had agreed to buy a total of 17 million doses of Indian-made vaccines, including 15 million doses of the Novavax shot.
So far, Ukraine has registered over 1.3 million COVID-19 cases and 25,309 deaths.
FDA grants priority review for GSK's gepotidacin gonorrhoea indication
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
FDA lifts pause on Valneva's chikungunya vaccine IXCHIQ for elderly, updates prescribing information
Anixa Biosciences begins US FDA approved IND transfer to support Phase 2 breast cancer vaccine trial
Pfizer and BioNTech receive EU regulatory backing for LP.8.1-adapted COVID-19 vaccine
Sanofi to acquire Vicebio for USD1.15bn to strengthen respiratory vaccine pipeline
Bavarian Nordic chikungunya vaccine enters Health Canada review process
SK bioscience submits IND for Phase 1/2 clinical trial of new influenza vaccine candidate
GC Biopharma secures Vietnamese approval for varicella vaccine BARYCELA
GSK announces submission of RSV vaccine Arexvy for FDA review
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Centivax raises USD45m to commercialise universal flu vaccine
CyanVac's nasal COVID vaccine shows promise in phase 1 trial
hVIVO supports Cidara Therapeutics' positive Phase 2b influenza study results